Optical Brightener Allergy: A Rare Sensitizer with a Classic History

The Tinopal CPY epidemic of 1969-71 is a landmark event in contact dermatitis history. Tinopal CPY, a pyrazoline-derivative optical brightener used in laundry detergents, was identified as a potent contact sensitizer when 167 patients at the Finsen Institute in Copenhagen developed contact dermatitis attributed to this compound. This represented one of the largest documented outbreaks of contact allergy linked to a single laundry product ingredient at the time. Following identification of CPY as the cause, it was removed from commercial formulations. The epidemic's resolution after product reformulation is a classic example of how contact dermatitis surveillance can protect public health.

Current optical brighteners — primarily DSBP-type stilbene derivatives used in modern laundry detergents — are much less sensitizing than the historical Tinopal CPY compound. Contact allergy to current brightener formulations is rare. For most people, optical brighteners in standard laundry detergents pose a very low risk of contact allergy. However, because brighteners are not labeled and some individuals may have unusual sensitivity, patients with unexplained recurrent dermatitis in clothing-contact patterns should consider optical brighteners in their differential — especially if reactions are occurring despite switching fragrance-free products.

Wood's lamp (a UV light source emitting at 365 nm) causes optical brighteners to fluoresce bright blue-white. When a dermatologist examines a patient's skin under Wood's lamp, areas where optical brighteners have transferred from fabric to skin will glow distinctly. This is a non-invasive tool that can confirm that brightener-to-skin transfer is occurring at sites of dermatitis — helping guide the clinical evaluation. Note that a positive Wood's lamp finding confirms exposure but not allergy: the fluorescence shows contact occurred, but patch testing is needed to confirm sensitization.

Unfortunately, optical brighteners are not required to be labeled on consumer laundry products in the United States, making this difficult to determine from packaging alone. Several strategies help: look for products specifically marketed as 'free and clear' (no dyes, no fragrance) — these often also omit brighteners; contact the manufacturer's customer service directly and ask whether the product contains optical brightening agents or fluorescent whitening agents; some products marketed for sensitive skin or baby laundry may be brightener-free. A simple home test: washed fabric fluoresces bright white under UV black light if brighteners are present.

Children's skin may be somewhat more permeable than adult skin, potentially increasing brightener absorption from fabrics. However, optical brightener contact allergy in children is not well-documented in the literature as a common pediatric dermatology diagnosis. Unexplained recurring eczema in infants and toddlers in fabric-contact distribution patterns warrants investigation of textile chemicals including brighteners, fragrances, and preservatives. Baby-specific laundry products that are marketed as fragrance-free and gentle often also omit optical brighteners, though this should be confirmed. A pediatric dermatologist can perform patch testing in older children where textile contact allergy is suspected.

Optical brighteners and fluorescent agents overlap but are not the same. Optical brighteners specifically refers to the fluorescent whitening agents used in laundry detergents, fabrics, and paper to make whites appear brighter — these are the compounds discussed on this page. Fluorescent agents is a broader category that also includes medical and laboratory staining dyes (fluorescein, rhodamine, eosin, acridine orange), fluorescent dyes in markers and highlighters, and fluorescent pigments in safety vests and high-visibility clothing. The allergy profiles are distinct: the Tinopal CPY epidemic is specific to laundry brighteners, while fluorescein angiography reactions are specific to medical ophthalmic dye use.

At-home allergy testing panels measure IgE antibodies in the blood — relevant for diagnosing hay fever, food allergies, pet allergies, and asthma triggers. Contact dermatitis from optical brighteners involves a different immune mechanism (Type IV T-cell response) that cannot be detected with blood IgE tests. Diagnosing optical brightener contact allergy requires in-person patch testing at a dermatology or contact dermatitis clinic, ideally with a Wood's lamp examination as a preliminary step. If you have respiratory allergies alongside suspected textile dermatitis, at-home IgE testing addresses the respiratory component while a dermatologist addresses the skin component.

It depends on whether the product also omits brighteners. Many fragrance-free and dye-free laundry detergents do also omit optical brighteners, and switching to such a product often resolves textile dermatitis — though patients typically attribute improvement to the fragrance removal. However, some fragrance-free products still contain brighteners. If switching to fragrance-free detergent does not resolve your dermatitis, optical brighteners remaining in the product may be a factor. Confirming brightener-free status directly with the manufacturer, or switching to a product specifically confirmed free of brighteners, is the next step.

Optical brightener dermatitis typically follows the distribution of fabric-to-skin contact, particularly in areas of friction, moisture, and close contact. The most commonly affected areas are the axillae (armpits), waistband area, inner thighs, collar and neck areas, and areas covered by underwear and socks. When brighteners are present in bed linens, the face, neck, and arms may be affected — particularly the thin-skinned eyelid area, where brightener penetration is enhanced. The precisely bordered distribution of dermatitis matching fabric edges is a characteristic feature that distinguishes textile contact allergy from other dermatitis patterns.

Some cosmetic products — particularly brightening foundations, whitening skincare products, and certain sunscreens — contain optical brightening agents to make skin appear lighter and more luminous. For patients sensitized to brighteners through laundry products, these cosmetics represent an additional exposure route that can cause facial contact dermatitis. The INCI ingredient name 'disodium distyrylbiphenyl disulfonate' is one to look for when reviewing cosmetic labels. Patients with known optical brightener sensitivity should check cosmetic ingredient lists and patch test new brightening products before full application.